Ticker
XOMACompany Name
XOMA ROYALTY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -2.98M | -6.63% | $ 44.95M |
3/31/2025 | $ 3.33M | 7.75% | $ 42.91M |
12/31/2024 | $ -10.84M | -38.03% | $ 28.49M |
9/30/2024 | $ -20.03M | -92.72% | $ 21.61M |
6/30/2024 | $ -10.2M | -66.94% | $ 15.24M |
3/31/2024 | $ -34.73M | -597.68% | $ 5.81M |
12/31/2023 | $ -39.24M | -824.78% | $ 4.76M |
9/30/2023 | $ -25.78M | -584.52% | $ 4.41M |
6/30/2023 | $ -24.65M | -611.28% | $ 4.03M |
3/31/2023 | $ -24.15M | -719.36% | $ 3.36M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for XOMA ROYALTY CORP is calculated as follows: EBITDA [ $ -10.95M ] / Revenues [ $ 2.23M ]
(=) EBITDA % [ -491.74% ]
Minimum
Dec 31, 2023
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |